Codexis Uses Its CodeEvolver(R) Protein Engineering Platform Technology to Develop an Enzyme Therapeutic Candidate for the Potential Treatment of Phenylketonuria (PKU) via Oral Administration
December 03, 2014 18:38 ET
|
Codexis
REDWOOD CITY, Calif., Dec. 3, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it has...
Codexis to Present at the LD Micro Main Event VII Conference on December 4
November 25, 2014 08:00 ET
|
Codexis
REDWOOD CITY, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will...
Codexis Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2014
November 04, 2014 16:03 ET
|
Codexis
REDWOOD CITY, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced financial...
Codexis Appoints Pam P. Cheng, Merck Global Executive, to Board of Directors
November 03, 2014 16:01 ET
|
Codexis
REDWOOD CITY, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the...
Codexis to Report Third Quarter 2014 Financial Results on November 4
October 21, 2014 08:00 ET
|
Codexis
REDWOOD CITY, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will...
Codexis Appoints Biotechnology Industry Veteran, Kathleen Glaub, to Board of Directors
September 22, 2014 08:00 ET
|
Codexis
REDWOOD CITY, Calif., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the...
Codexis Reports Financial Results for the Second Quarter of 2014
August 06, 2014 16:01 ET
|
Codexis
REDWOOD CITY, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its...
Codexis to Announce Second Quarter 2014 Financial Results on August 6, 2014
July 31, 2014 16:36 ET
|
Codexis
REDWOOD CITY, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will...
Gordon Sangster to Join Codexis as Senior Vice President & Chief Financial Officer
July 28, 2014 16:01 ET
|
Codexis
REDWOOD CITY, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that...
Codexis Announces Technology Collaboration and License Agreement With GSK
July 14, 2014 16:01 ET
|
Codexis
Codexis to Receive Up to $25 Million of Initial Payments, Plus Additional Milestone and Royalty Opportunities
Codexis to Host a Conference Call on July 15, 2014 at 8:30 a.m. ET / 5:30 a.m....